ICHG2016

Sessions

The 13th International Congress of Human Genetics / Concurrent Invited Session

[CIS4] Concurrent Invited Session 4
Regenerative Medicine

April 04, 2016 15:50 - 17:50

[Convener] Haruhisa Inoue（Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan）

[Convener] John D. Sinden（ReNeuron Limited, UK）

In Japan, after the recent implementation of the new law for regulating regenerative medicine, the landscape of stem cell-based medicine has been changing very rapidly. In addition, the world’s first clinical trial using patient iPSCs was started last September. Now an opportunity to lead the world has presented itself to Japan.
Speaking attending this symposium, we have 4 leading researchers in the translation of stem cell science into regenerative medicine and towards clinical trials. We look forward to vibrant and rewarding discussions.

Mon(2)-CIS4-1 Stem cell therapies in Europe: Taking the CTX human neural stem cell product to clinical trials in disabled stroke patients [Speaker] John D. Sinden:1 1:ReNeuron Limited, UK
Mon(2)-CIS4-2 Engineering the Morphogenesis of Pluripotent Stem Cells [Speaker] Todd C. McDevitt:1 1:Gladstone Institutes of Cardiovascular Diseases; Bioengineering and Therapeutics at the University of California, San Francisco, USA
Mon(2)-CIS4-3 Retinal stem cells from bench to clinic [Speaker] Petr Baranov:1 1:Schepens Eye Research Institute, Mssachusetts Eye & Ear; Department of Ophthalmology, Harvard Medical School, Boston MA, USA
Mon(2)-CIS4-4 Possible future of regenerative medicine using cell sheet engineering and iPS cell technology [Speaker] Katsuhisa Matsuura:1 1:Tokyo Women's Medical University, Japan

Advanced Search

ICHG2016 My Schedule

Sessions

Session List

Program Overview

Speakers

Exhibitors

My List

My Schedule

My Abstracts